Bayer in frame to win first EU nod for high-precision cancer drug
(Reuters) – Europe’s drug regulator has recommended approving Bayer’s Vitrakvi, putting the medicine on track to become the first in Europe to tackle tumours with a specific genetic mutation regardless…